Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Multiple Myeloma 323 Lymphoma 86 Leukemia 63 Precursor Cell Lymphoblastic Leukemia-Lymphoma 62 Lymphoma, Non-Hodgkin 62 Hodgkin Disease 60 Leukemia, Lymphocytic, Chronic, B-Cell 58 Neoplasms, Plasma Cell 56 Leukemia, Myeloid, Acute 50 Lymphoma, Mantle-Cell 47 Myelodysplastic Syndromes 44 Lymphoma, Follicular 44 Myeloproliferative Disorders 42 Lymphoma, Large B-Cell, Diffuse 42 Lymphoma, B-Cell, Marginal Zone 40 Burkitt Lymphoma 40 Neoplasms 39 Lymphoma, Large-Cell, Immunoblastic 38 Primary Myelofibrosis 37 Lymphoma, T-Cell, Cutaneous 35 Sezary Syndrome 33 Mycosis Fungoides 33 Leukemia, Myeloid, Chronic-Phase 33 Leukemia, Myeloid, Accelerated Phase 33 Congenital Abnormalities 31 Hematologic Neoplasms 30 Blast Crisis 30 Leukemia, Hairy Cell 29 Breast Neoplasms 29 Leukemia, Myelomonocytic, Chronic 27

Interventions

Surveys and Questionnaires 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Anosmia × Plasma cell × Clear all

NCT04716153 2026-01-20

RE-NEZ-SENS

University Hospital, Montpellier

Phase NA Terminated

LymphoidPlasma cell

Anosmia, Lymphoma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡